What's new? Log in Free sign up

Quantum-Si (QSI) News and press releases

Company Profile

News

From Benzinga Pro

Stocks That Hit 52-Week Lows On Friday

On Friday, 469 companies hit new 52-week lows.

Stocks That Hit 52-Week Lows On Friday

On Friday, 497 companies set new 52-week lows.

Why Quantum-Si (QSI) Stock Is Nosediving

Earnings, News, Penny Stocks

Quantum-Si Inc (NASDAQ: QSI) share are trading lower by 7.87% to $1.99 during Monday's session after the company reported fourth-quarter financial results. What Happened?

UPDATE: Quantum-Si Q4 Adj. EPS $(0.17) Beats $(0.20) Estimate

Quantum-Si (NASDAQ:QSI) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.20) by 15 percent. This is a 19.05 percent increase over losses of $(0.21) per share from the same

Quantum-Si Q4 Adj. EPS $(0.17) Beats $(0.20) Estimate

Earnings, News, Penny Stocks, Small Cap

Quantum-Si (NASDAQ: QSI) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.20) by 15 percent. This is a 19.05 percent increase over losses of $(0.21) per share from the same period last year.

Earnings Scheduled For March 6, 2023

Companies Reporting Before The Bell • Passage Bio (NASDAQ:PASG) is estimated to report earnings for its fourth quarter.

Quantum-Si's Earnings Outlook

Quantum-Si And Aviva Systems Biology Partner To Co-Develop Sample Preparation Kits For Protein Sequencing

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it entered into a partnership with Aviva Systems

Stocks That Hit 52-Week Lows On Friday

During Friday's trading, 71 companies set new 52-week lows.

Press releases

From Benzinga Pro

Quantum-Si to Participate in B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation, Virtual Conference

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced that it will be participating in B. Riley Securities' Life Sciences Tools Conference -

Resolve Biosciences Announces Appointment of John Stark as Chief Executive Officer

Life sciences tools veteran brings decades of experience leading successful teams, commercializing industry-defining technology platforms, and scaling global organizations Resolve Biosciences, a company pioneering

Quantum-Si to Participate in the 43rd Annual Cowen Health Care Conference

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced that it will be participating in the 43rd Annual Cowen Health Care Conference taking place

Quantum-Si to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced that it will report financial results for the fourth quarter and full year 2022 before

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Quantum-Si Incorporated for Potential Breaches of Fiduciary Duty By Its Board of Directors

NEW YORK, NY / ACCESSWIRE / January 26, 2023 / Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.